×




Kramer Pharmaceuticals, Inc., Spanish Version SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

Case Study SWOT Analysis Solution

Case Study Description of Kramer Pharmaceuticals, Inc., Spanish Version


The 12-year career of Mr. Bob Marsh is traced, from recruitment to termination. Data on Kramer's sales management, performance evaluation, compensation, and sales training systems are given.

Authors :: Derek A. Newton

Topics :: Sales & Marketing

Tags :: Compensation, Firing, Sales, SWOT Analysis, SWOT Matrix, TOWS, Weighted SWOT Analysis

Swot Analysis of "Kramer Pharmaceuticals, Inc., Spanish Version" written by Derek A. Newton includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Kramer Kramer's facing as an external strategic factors. Some of the topics covered in Kramer Pharmaceuticals, Inc., Spanish Version case study are - Strategic Management Strategies, Compensation, Firing, Sales and Sales & Marketing.


Some of the macro environment factors that can be used to understand the Kramer Pharmaceuticals, Inc., Spanish Version casestudy better are - – increasing transportation and logistics costs, increasing inequality as vast percentage of new income is going to the top 1%, there is backlash against globalization, technology disruption, wage bills are increasing, supply chains are disrupted by pandemic , competitive advantages are harder to sustain because of technology dispersion, increasing government debt because of Covid-19 spendings, digital marketing is dominated by two big players Facebook and Google, etc



12 Hrs

$59.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

24 Hrs

$49.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now

48 Hrs

$39.99
per Page
  • 100% Plagiarism Free
  • On Time Delivery | 27x7
  • PayPal Secure
  • 300 Words / Page
  • Buy Now







Introduction to SWOT Analysis of Kramer Pharmaceuticals, Inc., Spanish Version


SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in Kramer Pharmaceuticals, Inc., Spanish Version case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Kramer Kramer's, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Kramer Kramer's operates in.

According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.




SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix


SWOT analysis of Kramer Pharmaceuticals, Inc., Spanish Version can be done for the following purposes –
1. Strategic planning using facts provided in Kramer Pharmaceuticals, Inc., Spanish Version case study
2. Improving business portfolio management of Kramer Kramer's
3. Assessing feasibility of the new initiative in Sales & Marketing field.
4. Making a Sales & Marketing topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Kramer Kramer's




Strengths Kramer Pharmaceuticals, Inc., Spanish Version | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The strengths of Kramer Kramer's in Kramer Pharmaceuticals, Inc., Spanish Version Harvard Business Review case study are -

High brand equity

– Kramer Kramer's has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Kramer Kramer's to keep acquiring new customers and building profitable relationship with both the new and loyal customers.

Training and development

– Kramer Kramer's has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in Kramer Pharmaceuticals, Inc., Spanish Version Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.

Successful track record of launching new products

– Kramer Kramer's has launched numerous new products in last few years, keeping in mind evolving customer preferences and competitive pressures. Kramer Kramer's has effective processes in place that helps in exploring new product needs, doing quick pilot testing, and then launching the products quickly using its extensive distribution network.

Learning organization

- Kramer Kramer's is a learning organization. It has inculcated three key characters of learning organization in its processes and operations – exploration, creativity, and expansiveness. The work place at Kramer Kramer's is open place that encourages instructiveness, ideation, open minded discussions, and creativity. Employees and leaders in Kramer Pharmaceuticals, Inc., Spanish Version Harvard Business Review case study emphasize – knowledge, initiative, and innovation.

Effective Research and Development (R&D)

– Kramer Kramer's has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study Kramer Pharmaceuticals, Inc., Spanish Version - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.

Digital Transformation in Sales & Marketing segment

- digital transformation varies from industry to industry. For Kramer Kramer's digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Kramer Kramer's has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.

Diverse revenue streams

– Kramer Kramer's is present in almost all the verticals within the industry. This has provided firm in Kramer Pharmaceuticals, Inc., Spanish Version case study a diverse revenue stream that has helped it to survive disruptions such as global pandemic in Covid-19, financial disruption of 2008, and supply chain disruption of 2021.

Sustainable margins compare to other players in Sales & Marketing industry

– Kramer Pharmaceuticals, Inc., Spanish Version firm has clearly differentiated products in the market place. This has enabled Kramer Kramer's to fetch slight price premium compare to the competitors in the Sales & Marketing industry. The sustainable margins have also helped Kramer Kramer's to invest into research and development (R&D) and innovation.

High switching costs

– The high switching costs that Kramer Kramer's has built up over years in its products and services combo offer has resulted in high retention of customers, lower marketing costs, and greater ability of the firm to focus on its customers.

Analytics focus

– Kramer Kramer's is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Derek A. Newton can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.

Strong track record of project management

– Kramer Kramer's is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.

Innovation driven organization

– Kramer Kramer's is one of the most innovative firm in sector. Manager in Kramer Pharmaceuticals, Inc., Spanish Version Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.






Weaknesses Kramer Pharmaceuticals, Inc., Spanish Version | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis

The weaknesses of Kramer Pharmaceuticals, Inc., Spanish Version are -

Skills based hiring

– The stress on hiring functional specialists at Kramer Kramer's has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.

High dependence on existing supply chain

– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Kramer Kramer's supply chain. Even after few cautionary changes mentioned in the HBR case study - Kramer Pharmaceuticals, Inc., Spanish Version, it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Kramer Kramer's vulnerable to further global disruptions in South East Asia.

Aligning sales with marketing

– It come across in the case study Kramer Pharmaceuticals, Inc., Spanish Version that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case Kramer Pharmaceuticals, Inc., Spanish Version can leverage the sales team experience to cultivate customer relationships as Kramer Kramer's is planning to shift buying processes online.

High cash cycle compare to competitors

Kramer Kramer's has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.

Compensation and incentives

– The revenue per employee as mentioned in the HBR case study Kramer Pharmaceuticals, Inc., Spanish Version, is just above the industry average. Kramer Kramer's needs to redesign the compensation structure and incentives to increase the revenue per employees. Some of the steps that it can take are – hiring more specialists on project basis, etc.

Slow decision making process

– As mentioned earlier in the report, Kramer Kramer's has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Kramer Kramer's even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.

Slow to harness new channels of communication

– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, Kramer Kramer's is slow explore the new channels of communication. These new channels of communication mentioned in marketing section of case study Kramer Pharmaceuticals, Inc., Spanish Version can help to provide better information regarding products and services. It can also build an online community to further reach out to potential customers.

High bargaining power of channel partners

– Because of the regulatory requirements, Derek A. Newton suggests that, Kramer Kramer's is facing high bargaining power of the channel partners. So far it has not able to streamline the operations to reduce the bargaining power of the value chain partners in the industry.

Interest costs

– Compare to the competition, Kramer Kramer's has borrowed money from the capital market at higher rates. It needs to restructure the interest payment and costs so that it can compete better and improve profitability.

Capital Spending Reduction

– Even during the low interest decade, Kramer Kramer's has not been able to do capital spending to the tune of the competition. This has resulted into fewer innovations and company facing stiff competition from both existing competitors and new entrants who are disrupting the industry using digital technology.

Low market penetration in new markets

– Outside its home market of Kramer Kramer's, firm in the HBR case study Kramer Pharmaceuticals, Inc., Spanish Version needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.




Opportunities Kramer Pharmaceuticals, Inc., Spanish Version | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The opportunities highlighted in the Harvard Business Review case study Kramer Pharmaceuticals, Inc., Spanish Version are -

Building a culture of innovation

– managers at Kramer Kramer's can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Sales & Marketing segment.

Lowering marketing communication costs

– 5G expansion will open new opportunities for Kramer Kramer's in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Sales & Marketing segment, and it will provide faster access to the consumers.

Identify volunteer opportunities

– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Kramer Kramer's can explore opportunities that can attract volunteers and are consistent with its mission and vision.

Creating value in data economy

– The success of analytics program of Kramer Kramer's has opened avenues for new revenue streams for the organization in the industry. This can help Kramer Kramer's to build a more holistic ecosystem as suggested in the Kramer Pharmaceuticals, Inc., Spanish Version case study. Kramer Kramer's can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.

Learning at scale

– Online learning technologies has now opened space for Kramer Kramer's to conduct training and development for its employees across the world. This will result in not only reducing the cost of training but also help employees in different part of the world to integrate with the headquarter work culture, ethos, and standards.

Increase in government spending

– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Kramer Kramer's can use these opportunities to build new business models that can help the communities that Kramer Kramer's operates in. Secondly it can use opportunities from government spending in Sales & Marketing sector.

Reforming the budgeting process

- By establishing new metrics that will be used to evaluate both existing and potential projects Kramer Kramer's can not only reduce the costs of the project but also help it in integrating the projects with other processes within the organization.

Manufacturing automation

– Kramer Kramer's can use the latest technology developments to improve its manufacturing and designing process in Sales & Marketing segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.

Redefining models of collaboration and team work

– As explained in the weaknesses section, Kramer Kramer's is facing challenges because of the dominance of functional experts in the organization. Kramer Pharmaceuticals, Inc., Spanish Version case study suggests that firm can utilize new technology to build more coordinated teams and streamline operations and communications using tools such as CAD, Zoom, etc.

Better consumer reach

– The expansion of the 5G network will help Kramer Kramer's to increase its market reach. Kramer Kramer's will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.

Using analytics as competitive advantage

– Kramer Kramer's has spent a significant amount of money and effort to integrate analytics and machine learning into its operations in the sector. This continuous investment in analytics has enabled, as illustrated in the Harvard case study Kramer Pharmaceuticals, Inc., Spanish Version - to build a competitive advantage using analytics. The analytics driven competitive advantage can help Kramer Kramer's to build faster Go To Market strategies, better consumer insights, developing relevant product features, and building a highly efficient supply chain.

Leveraging digital technologies

– Kramer Kramer's can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.

Buying journey improvements

– Kramer Kramer's can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. Kramer Pharmaceuticals, Inc., Spanish Version suggest that firm can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.




Threats Kramer Pharmaceuticals, Inc., Spanish Version External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis


The threats mentioned in the HBR case study Kramer Pharmaceuticals, Inc., Spanish Version are -

Stagnating economy with rate increase

– Kramer Kramer's can face lack of demand in the market place because of Fed actions to reduce inflation. This can lead to sluggish growth in the economy, lower demands, lower investments, higher borrowing costs, and consolidation in the field.

Barriers of entry lowering

– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Kramer Kramer's with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.

Technology disruption because of hacks, piracy etc

– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.

Consumer confidence and its impact on Kramer Kramer's demand

– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.

High dependence on third party suppliers

– Kramer Kramer's high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.

Regulatory challenges

– Kramer Kramer's needs to prepare for regulatory challenges as consumer protection groups and other pressure groups are vigorously advocating for more regulations on big business - to reduce inequality, to create a level playing field, to product data privacy and consumer privacy, to reduce the influence of big money on democratic institutions, etc. This can lead to significant changes in the Sales & Marketing industry regulations.

Capital market disruption

– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Kramer Kramer's.

Increasing wage structure of Kramer Kramer's

– Post Covid-19 there is a sharp increase in the wages especially in the jobs that require interaction with people. The increasing wages can put downward pressure on the margins of Kramer Kramer's.

Technology acceleration in Forth Industrial Revolution

– Kramer Kramer's has witnessed rapid integration of technology during Covid-19 in the Sales & Marketing industry. As one of the leading players in the industry, Kramer Kramer's needs to keep up with the evolution of technology in the Sales & Marketing sector. According to Mckinsey study top managers believe that the adoption of technology in operations, communications is 20-25 times faster than what they planned in the beginning of 2019.

New competition

– After the dotcom bust of 2001, financial crisis of 2008-09, the business formation in US economy had declined. But in 2020 alone, there are more than 1.5 million new business applications in United States. This can lead to greater competition for Kramer Kramer's in the Sales & Marketing sector and impact the bottomline of the organization.

Easy access to finance

– Easy access to finance in Sales & Marketing field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Kramer Kramer's can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.

Environmental challenges

– Kramer Kramer's needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Kramer Kramer's can take advantage of this fund but it will also bring new competitors in the Sales & Marketing industry.

Shortening product life cycle

– it is one of the major threat that Kramer Kramer's is facing in Sales & Marketing sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.




Weighted SWOT Analysis of Kramer Pharmaceuticals, Inc., Spanish Version Template, Example


Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study Kramer Pharmaceuticals, Inc., Spanish Version needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants. We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –

First stage for doing weighted SWOT analysis of the case study Kramer Pharmaceuticals, Inc., Spanish Version is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.

Second stage for conducting weighted SWOT analysis of the Harvard case study Kramer Pharmaceuticals, Inc., Spanish Version is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.

Third stage of constructing weighted SWOT analysis of Kramer Pharmaceuticals, Inc., Spanish Version is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Kramer Kramer's needs to make to build a sustainable competitive advantage.



--- ---

Cameco in Kyrgyzstan: Corporate Social Responsibility Abroad SWOT Analysis / TOWS Matrix

Pratima Bansal, John Scarfe, Russell Johnston , Leadership & Managing People


A Note on Healthcare IT and Applications to the Healthcare Industry SWOT Analysis / TOWS Matrix

Robert F. Higgins, Diana Maichin , Innovation & Entrepreneurship


What a Great Idea SWOT Analysis / TOWS Matrix

Myra M. Hart, Susan S. Harmeling , Innovation & Entrepreneurship


Salomon Brothers (B) SWOT Analysis / TOWS Matrix

Lynn Sharp Paine , Leadership & Managing People


Hasbro Games: POX (A) SWOT Analysis / TOWS Matrix

David B. Godes, Elie Ofek , Sales & Marketing


Rudi Gassner and the Executive Committee of BMG International (A) SWOT Analysis / TOWS Matrix

Linda A. Hill, Katherine S. Weber , Leadership & Managing People


Auctions SWOT Analysis / TOWS Matrix

Sherwood C. Frey, Dana Clyman , Strategy & Execution


Sunbeam Television (A) SWOT Analysis / TOWS Matrix

V. Kasturi Rangan, Scott Lathrop , Sales & Marketing